                         SEQUENCE LISTING

<110>  Sorbonne Universit
       Centre National de la Recherche Scientifique
 
<120>  Synthetic peptides inducing immunogenic cell death

<130>  CLBEclhf F2478 28EP

<140>  EP18306454.2
<141>  2018-11-06

<160>  34    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Homo sapiens

<400>  1

Lys Arg Phe Tyr Val Val Met Trp Lys Lys 
1               5                   10  


<210>  2
<211>  10
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X being (D)K

<400>  2

Xaa Arg Phe Tyr Val Val Met Trp Lys Xaa 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being Ac

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X being NH2

<400>  3

Xaa Arg Phe Tyr Val Val Met Trp Lys Xaa 
1               5                   10  


<210>  4
<211>  12
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being Ac

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being NH2

<400>  4

Xaa Lys Arg Phe Tyr Val Val Met Trp Lys Lys Xaa 
1               5                   10          


<210>  5
<211>  11
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X being OH

<400>  5

Xaa Ala Phe Tyr Val Val Met Trp Lys Xaa Xaa 
1               5                   10      


<210>  6
<211>  10
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X being (NLe)W

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X being OH

<400>  6

Xaa Arg Phe Tyr Val Val Xaa Lys Xaa Xaa 
1               5                   10  


<210>  7
<211>  7
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X being OH

<400>  7

Phe Tyr Val Val Xaa Trp Xaa 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X being NH2

<400>  8

Phe Tyr Val Val Xaa Trp Xaa 
1               5           


<210>  9
<211>  8
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being Ac

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X being OH

<400>  9

Xaa Phe Tyr Val Val Xaa Trp Xaa 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being Ac

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X being NH2

<400>  10

Xaa Phe Tyr Val Val Xaa Trp Xaa 
1               5               


<210>  11
<211>  9
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X being OH

<400>  11

Xaa Phe Tyr Val Val Xaa Trp Xaa Xaa 
1               5                   


<210>  12
<211>  7
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X being OH

<400>  12

Phe Tyr Val Val Lys Trp Xaa 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  X being NH2

<400>  13

Phe Tyr Val Val Lys Trp Xaa 
1               5           


<210>  14
<211>  12
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X being pseudopeptide bond linking the two amino acid residues on
       either side of this term

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being OH

<400>  14

Xaa Xaa Arg Phe Tyr Val Val Met Trp Lys Xaa Xaa 
1               5                   10          


<210>  15
<211>  12
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  X being a pseudopeptide bond linking the two amino acid residues 
       on either side of this term

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being OH

<400>  15

Xaa Arg Phe Tyr Val Val Met Trp Xaa Lys Xaa Xaa 
1               5                   10          


<210>  16
<211>  13
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X being a pseudopeptide bond linking the two amino acid residues 
       on either side of this term

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  X being a pseudopeptide bond linking the two amino acid residues 
       on either side of this term

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  X being OH

<400>  16

Xaa Xaa Arg Phe Tyr Val Val Met Trp Xaa Lys Xaa Xaa 
1               5                   10              


<210>  17
<211>  12
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X being a pseudopeptide bond linking the two amino acid residues 
       on either side of this term

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being OH

<400>  17

Xaa Xaa Arg Phe Tyr Val Val Xaa Trp Lys Xaa Xaa 
1               5                   10          


<210>  18
<211>  12
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X being a pseudopeptide bond linking the two amino acid residues 
       on either side of this term

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being OH

<400>  18

Xaa Xaa Arg Phe Tyr Val Val Leu Trp Lys Xaa Xaa 
1               5                   10          


<210>  19
<211>  12
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X being a pseudopeptide bond linking the two amino acid residues 
       on either side of this term

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being OH

<400>  19

Xaa Xaa Arg Phe Tyr Val Val Ile Trp Lys Xaa Xaa 
1               5                   10          


<210>  20
<211>  12
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  X being a pseudopeptide bond linking the two amino acid residues 
       on either side of this term

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  X being NLe

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  X being (D)K

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  X being OH

<400>  20

Xaa Xaa Arg Phe Phe Val Val Xaa Trp Lys Xaa Xaa 
1               5                   10          


<210>  21
<211>  14
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  D-proline

<400>  21

Phe Tyr Val Val Lys Trp Pro Pro Leu Ser Val Lys Val Val 
1               5                   10                  


<210>  22
<211>  14
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  D-proline

<400>  22

Phe Phe Val Val Lys Trp Pro Pro Leu Ser Val Lys Val Val 
1               5                   10                  


<210>  23
<211>  18
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  D-proline

<400>  23

Pro Pro Arg Phe Tyr Val Val Met Trp Lys Gly Leu Ser Val Lys Val 
1               5                   10                  15      


Val Asn 
        


<210>  24
<211>  20
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  D-proline

<400>  24

Ser Arg Phe Tyr Val Val Met Trp Lys Pro Pro Gly Ile Ser Val Lys 
1               5                   10                  15      


Val Val Lys Ser 
            20  


<210>  25
<211>  20
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  D-proline

<400>  25

Ser Arg Phe Tyr Val Val Met Trp Lys Pro Pro Gly Leu Ser Val Lys 
1               5                   10                  15      


Val Val Asn Ser 
            20  


<210>  26
<211>  20
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  RNMe

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  D-proline

<400>  26

Ser Arg Phe Tyr Val Val Met Trp Lys Pro Pro Gly Leu Ser Val Lys 
1               5                   10                  15      


Val Val Asn Ser 
            20  


<210>  27
<211>  20
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  RNMe

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  NLe

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  D-proline

<400>  27

Ser Arg Phe Tyr Val Val Xaa Trp Lys Pro Pro Gly Leu Ser Val Lys 
1               5                   10                  15      


Val Val Asn Ser 
            20  


<210>  28
<211>  20
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  RNMe

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  NLe

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  D-proline

<400>  28

Ser Arg Phe Tyr Val Val Xaa Trp Lys Pro Pro Gly Leu Ala Val Lys 
1               5                   10                  15      


Val Val Asn Ser 
            20  


<210>  29
<211>  20
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  D-proline

<400>  29

Ser Arg Phe Tyr Val Val Met Trp Lys Pro Pro Ser Arg Phe Tyr Val 
1               5                   10                  15      


Val Met Trp Lys 
            20  


<210>  30
<211>  20
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  D-proline

<400>  30

Ser Arg Phe Tyr Val Val Met Trp Lys Pro Pro Gly Leu Ser Val Lys 
1               5                   10                  15      


Val Val Asn Gly 
            20  


<210>  31
<211>  22
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  D-proline

<400>  31

Ser Arg Phe Tyr Val Val Met Trp Lys Gln Pro Pro Ser Gly Leu Ser 
1               5                   10                  15      


Val Lys Val Val Asn Ser 
            20          


<210>  32
<211>  22
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  RNMe

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  D-proline

<400>  32

Ser Arg Phe Tyr Val Val Met Trp Lys Gln Pro Pro Ser Gly Leu Ser 
1               5                   10                  15      


Val Lys Val Val Asn Ser 
            20          


<210>  33
<211>  22
<212>  PRT
<213>  Homo sapiens


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  RNMe

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  NLe

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  D-proline

<400>  33

Ser Arg Phe Tyr Val Val Xaa Trp Lys Gln Pro Pro Ser Gly Leu Ser 
1               5                   10                  15      


Val Lys Val Val Asn Ser 
            20          


<210>  34
<211>  18
<212>  PRT
<213>  Homo sapiens

<400>  34

Pro Pro Arg Phe Phe Val Val Met Trp Lys Gly Leu Ser Val Lys Val 
1               5                   10                  15      


Val Asn 
        


